Structure of EB-42486 - a potent, oral inhibitor of leucine-rich repeat kinase 2 (LRRK2)

oral G2019S-LRRK2 mut.-selective kinase inh.

>70x sel. for ParkinsonÕs mut. over WT, non-BP

from 50k cmpd HTS + homology-based opt.

J. Med. Chem., Nov. 16, 2020

ESCAPE Bio, South San Francisco, CA

EB-42486 (ESCAPE Bio oral G2019S-LRRK2 mutant-selective kinase inhibitor)


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.